The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

“It is a progressive condition eventually leading to kidney failure requiring dialysis or ... including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide ...

Tuttle focused on Novo Nordisk’s (Novo’s) Ozempic (semaglutide) to highlight the progress made in GLP-1 for the management of diabetic kidney disease. The discussion at AHA emphasised that the ...

Study finds yet another use for popular diabetes and obesity drugs - Several new uses have been found for the drugs ...

including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza). The results showed that compared to placebo, GLP-1 receptor agonists reduced the risk of ...

Giovanni E. Ferreira, University of Sydney and Christina Abdel Shaheed, University of Sydney The drug semaglutide, commonly ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...